Clinical Trial Diversity, Equity, and Inclusion: Roadmap of the Cardiothoracic Surgical Trials Network

被引:0
|
作者
Lala, Anuradha [1 ]
Louis, Clauden
Vervoort, Dominique [3 ]
Iribarne, Alexander [4 ]
Rao, Aarti
Taddei-Peters, Wendy C. [5 ]
Raymond, Samantha
Bagiella, Emilia
O'Gara, Patrick [6 ]
Thourani, Vinod H. [7 ]
Badhwar, Vinay [8 ]
Chikwe, Joanna [9 ]
Jessup, Mariell [10 ]
Jeffries, Neal [11 ]
Moskowitz, Alan J.
Gelijns, Annetine C. [2 ]
Rodriguez, Carlos J. [12 ]
机构
[1] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Med Cardiol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Populat Hlth Sci & Policy, One Gustave L Levy Pl,Box 1077, New York, NY 10029 USA
[3] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[4] Staten Isl Univ Hosp, Northwell Hlth, Dept Cardiothorac Surg, Staten Isl, NY USA
[5] Natl Heart Lung & Blood Inst, Div Cardiovasc Sci, NIH, Bethesda, MD USA
[6] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA USA
[7] Piedmont Heart Inst, Marcus Valve Ctr, Dept Cardiovasc Surg, Atlanta, GA USA
[8] West Virginia Univ, Dept Cardiovasc & Thorac Surg, Morgantown, WV USA
[9] CEDARS SINAI MED CTR, DEPT CARDIAC SURG, LOS ANGELES, CA USA
[10] Amer Heart Assoc, Dallas, TX USA
[11] NHLBI, Off Biostat Res, NIH, Bethesda, MD USA
[12] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Med Cardiol Epidemiol & Populat Hlth, Bronx, NY USA
来源
ANNALS OF THORACIC SURGERY | 2024年 / 118卷 / 06期
基金
加拿大健康研究院;
关键词
VALVULAR HEART-DISEASE; UNDER-REPRESENTATION; ATRIAL-FIBRILLATION; AFRICAN-AMERICANS; RACE; OUTCOMES; FAILURE; SURGERY; REPLACEMENT; MODERATE;
D O I
10.1016/j.athoracsur.2024.03.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND There is a recognized lack of diversity among patients enrolled in cardiovascular interventional and surgical trials. Diverse patient representation in clinical trials is necessary to enhance generalizability of findings, which may lead to better outcomes across broader populations. The Cardiothoracic Surgical Trials Network (CTSN) recently developed a plan of action to increase diversity among participating investigators and trial participants and is the focus of this review. METHODS A review of literature and enrollment data from CTSN trials was conducted. RESULTS CTSN completed more than a dozen major clinical trials (2008-2022), enrolling >4000 patients, of whom 30% were women, 11% were non-White, and 5.6% were Hispanic. CTSN also completed trials of hospitalized patients with coronavirus disease 2019, wherein enrollment was more diverse, with 42% women, and 58% were Asian, Black, Hispanic, or from another underrepresented racial group. The discrepancy in diversity of enrollment between cardiac surgery trials and coronavirus disease trials highlights the need for a more comprehensive understanding of (1) the prevalence of underlying disease requiring cardiac interventions across broad populations, (2) differences in access to care and referral for cardiac surgery, and (3) barriers to enrollment in cardiac surgery trials. CONCLUSIONS Committed to diversity, CTSN's multifaceted action plan includes developing site-specific enrollment targets, collecting social determinants of health data, understanding reasons for nonparticipation, recruiting sites that serve diverse populations, emphasizing greater diversity among clinical trial teams, and implicit bias training. The CTSN will prospectively assess how these interventions influence enrollment as we work to ensure trial participants are more representative of the communities we serve. (Ann Thorac Surg 2024;118:1327-37) (c) 2024 by The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:1327 / 1337
页数:11
相关论文
共 50 条
  • [1] Diversity, Equity, and Inclusion in Clinical Trials
    Keegan, Grace
    Crown, Angelena
    Joseph, Kathie-Ann
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (01) : 221 - 232
  • [2] The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership
    Snyder, Rebecca A.
    Burtness, Barbara
    Cho, May
    Del Rivero, Jaydira
    Doroshow, Deborah B.
    Hitchcock, Kathryn E.
    Kalyan, Aparna
    Kim, Christina A.
    Lukovic, Jelena
    Parikh, Aparna R.
    Sanford, Nina N.
    Singh, Bhuminder
    Shen, Chan
    Shroff, Rachna T.
    Vijayvergia, Namrata
    Goodman, Karyn A.
    Kunz, Pamela L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (10): : 1132 - 1138
  • [3] The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative
    Kuaban, Alice
    Croker, Alysha K.
    Keefer, Jeffrey
    Valentino, Leonard A.
    Bierer, Barbara E.
    Boateng, Stephen
    Dimichele, Donna
    Fogarty, Patrick
    Gibson, C. Michael
    Hood, Anna M.
    Hubbard, Lloryn
    Isgro, Antonella
    Knobe, Karin
    Lake, Leslie
    Martin, Iman
    Reid, Michel
    Roberts, Jonathan C.
    Tomlinson, Wendy
    Tunji-Ajayi, Lanre
    Van Spall, Harriette G. C.
    Voltz-Girolt, Caroline
    Wheeler, Allison P.
    Mast, Alan E.
    Seremetis, Stephanie
    BLOOD ADVANCES, 2025, 9 (04) : 687 - 695
  • [4] Diversity, Equity, and Inclusion in Local Clinical Trials
    Annam, Saketh
    Hashtjin, Solmaz Ramezani
    Khan, Shayan
    Staugaitis, Abbey
    Streib, Christopher
    NEUROLOGY, 2023, 100 (17)
  • [5] Diversity and Inclusion in Clinical Trials Are Preconditions for Equity
    Schmaling, Karen B.
    CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE, 2022, 29 (02) : 94 - 96
  • [6] The Roadmap to Integrate Diversity, Equity, and Inclusion in Hematology Clinical Trials: An ASH Initiative Submitted on Behalf of the Entire Roadmap to Improve DEI in Clinical Trials Working Group
    Kuaban, Alice
    Croker, Alysha
    Keefer, Jeffrey
    Valentino, Leonard A.
    Mast, Alan E.
    Seremetis, Stephanie Valer
    BLOOD, 2024, 144 : 5013 - 5014
  • [7] Strategies to improve diversity, equity, and inclusion in clinical trials
    Kahn, Justine M.
    Gray, Darrell M.
    Oliveri, Jill M.
    Washington, Chasity M.
    DeGraffinreid, Cecilia R.
    Paskett, Electra D.
    CANCER, 2022, 128 (02) : 216 - 221
  • [8] The Cardiothoracic Surgical Trials Network: Implications for clinical practice
    O'Gara, Patrick T.
    Sundt, Thoralf M.
    Acker, Michael A.
    David, Tirone E.
    Michler, Robert E.
    Borger, Michael A.
    Ailawadi, Gorav
    Thourani, Vinod H.
    Gillinov, A. Marc
    Damiano, Ralph J.
    Mack, Michael J.
    Lee, Richard
    Rose, Eric A.
    Gardner, Timothy J.
    Miller, Marissa A.
    Weisel, Richard D.
    Gelijns, Annetine C.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (06): : 1938 - 1956
  • [9] Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsor
    Versavel, Stacey
    Subasinghe, Alicia
    Johnson, Kenasha
    Golonski, Nicole
    Muhlhausen, Janna
    Perry, Pamela
    Sanchez, Raymond
    CONTEMPORARY CLINICAL TRIALS, 2023, 126
  • [10] Recommendations to promote equity, diversity and inclusion in decentralized clinical trials
    Aiyegbusi, Olalekan Lee
    Cruz Rivera, Samantha
    Kamudoni, Paul
    Anderson, Nicola
    Collis, Philip
    Denniston, Alastair K.
    Harding, Rosie
    Hughes, Sarah E.
    Khunti, Kamlesh
    Kotecha, Dipak
    Krumholz, Harlan
    Liu, Xiaoxuan
    Mcmullan, Christel
    Molony-Oates, Barbara
    Monteiro, Joao
    Myles, Puja
    Rantell, Khadija Rerhou
    Soltys, Katherine
    Verdi, Ravinder
    Wilson, Roger
    Calvert, Melanie J.
    NATURE MEDICINE, 2024, : 3075 - 3084